Concepedia

Author

Michael Vredenburg

Seattle Cancer Care AllianceORCID

Also Known As

M. R. Vredenburg, M. Vredenburg, M.R. Vredenburg, Michael R. Vredenburg, Michael Vredenburg

71

Publications

309

Citations

8

H-Index

19

Concepts

All Affiliations

Seattle Cancer Care AllianceUniversity of WashingtonMassachusetts General HospitalUniversity of PennsylvaniaRoswell Park Comprehensive Cancer Center
MV

About

Michael Vredenburg is an author at Seattle Cancer Care Alliance specializing in health sciences, medicine, and immunodeficiencies.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

85

2

Medicine

2

2

85

3

Immunology

1

1

70

4

Pharmacology

1

1

15

5

Rheumatology

1

1

70

Michael Vredenburg

×

6

Publications

219

Citations

6

H-Index

YearCitations

Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance

Michael Vredenburg, Iwao Ojima, Jean Veith,

JNCI Journal of the National Cancer Institute

2001

80

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

Hanny Al‐Samkari, Debbie Jiang, Terry Gernsheimer,

British Journal of Haematology

2022

70

Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures

Christine Barnett, Deirdre Mladsi, Michael Vredenburg,

Journal of Medical Economics

2018

31

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

Tracy A. Brooks, Kieran L. O’Loughlin, Hans Minderman,

Investigational New Drugs

2006

15

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia

Shivi Jain, Terry Gernsheimer, Scott Kolodny,

Platelets

2023

12

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

Hanny Al‐Samkari, Debbie Jiang, Terry Gernsheimer,

Research and Practice in Thrombosis and Haemostasis

2023

11

Page 1